Peppies Peppies tortoise mark
Bpc 157

Frequently Asked Question

What happens at the July 2026 advisory committee meeting?

On July 23-24, 2026, the FDA's Pharmacy Compounding Advisory Committee reviews seven peptides, hears presentations and public comment, and votes a recommendation on whether each should be added to the 503A bulks list. The vote is advisory; the FDA makes the final call afterward.1

← Back to all FAQs

Related Questions

Is BPC-157 legal in the United States in 2026? → Has the FDA approved BPC-157 for any use? → Does removal from Category 2 mean BPC-157 is now approved? →

Get notified

Be ready the moment the comment window opens

The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.

Get notified →